INCOME STATEMENT
Orchid Pharma Ltd.
BSE
Jul 04
755.30
+7.90 (+ 1.06%)
Volume
8752
Prev. Close
747.40
Open Price
747.95
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jul 04
756.05
+8.50 (+ 1.14%)
Volume
163098
Prev. Close
747.55
Open Price
753.30
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
|
ISIN No
|
INE191A01027
|
Market Cap. ( ₹ in Cr. )
|
3834.62
|
P/BV
|
3.13
|
Book Value ( ₹ )
|
241.38
|
|
BSE Code
|
524372
|
52 Week High/Low ( ₹ )
|
1997/604
|
FV/ML
|
10/1
|
P/E(X)
|
38.48
|
|
NSE Code
|
ORCHPHARMAEQ
|
Book Closure
|
09/08/2023
|
EPS ( ₹ )
|
19.65
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 921.93 | 816.11 | 656.66 | 554.26 | 450.23 |
| Other Operating Revenues | 0.00 | 3.25 | 9.24 | 2.71 | 0.46 |
| Total Operating Revenues | 921.93 | 819.37 | 665.90 | 556.97 | 450.70 |
| | | | | | |
| Other Income | 31.93 | 30.39 | 19.43 | 9.00 | 6.48 |
| Total Revenue | 953.86 | 849.76 | 685.33 | 565.98 | 457.17 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 585.46 | 528.35 | 406.10 | 336.80 | 244.96 |
| Purchase Of Stock-In Trade | 2.61 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -43.85 | -43.89 | -21.48 | -22.73 | -15.69 |
| Employee Benefit Expenses | 86.36 | 69.64 | 65.35 | 60.21 | 64.40 |
| Finance Costs | 14.54 | 16.33 | 32.23 | 87.02 | 51.34 |
| Depreciation And Amortisation Expenses | 34.44 | 33.22 | 54.79 | 32.01 | 108.90 |
| Other Expenses | 167.81 | 154.59 | 132.31 | 125.44 | 99.14 |
| Total Expenses | 847.37 | 758.23 | 669.29 | 618.75 | 553.04 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 106.48 | 91.52 | 16.04 | -52.77 | -95.87 |
| | | | | | |
| Exceptional Items | 0.00 | 0.00 | 39.21 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 106.48 | 91.52 | 55.25 | -52.77 | -95.87 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Deferred Tax | 0.00 | -3.23 | 0.00 | 0.00 | 0.00 |
| Total Tax Expenses | 0.00 | -3.23 | 0.00 | 0.00 | 0.00 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 106.48 | 94.75 | 55.25 | -52.77 | -95.87 |
| | | | | | |
| Profit/Loss From Continuing Operations | 106.48 | 94.75 | 55.25 | -52.77 | -95.87 |
| | | | | | |
| Profit/Loss From Discontinuing Operations | 0.00 | 0.00 | -1.06 | 47.96 | -21.28 |
| Net Profit/Loss From Discontinuing Operations | 0.00 | 0.00 | -1.06 | 47.96 | -21.28 |
| Profit/Loss For The Period | 106.48 | 94.75 | 54.19 | -4.81 | -117.15 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 20.99 | 19.59 | 13.28 | -1.18 | -28.70 |
| Diluted EPS (Rs.) | 20.99 | 19.59 | 13.28 | -1.18 | -28.70 |